(NASDAQ: CRON) Cronos Group's forecast annual earnings growth rate of -34.53% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 42.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.73%.
Cronos Group's earnings in 2025 is $49,443,000.On average, 2 Wall Street analysts forecast CRON's earnings for 2025 to be $5,781,285, with the lowest CRON earnings forecast at -$15,416,761, and the highest CRON earnings forecast at $26,979,331.
In 2026, CRON is forecast to generate $23,125,141 in earnings, with the lowest earnings forecast at $23,125,141 and the highest earnings forecast at $23,125,141.